Suride

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Suride

Quick Facts: Sulpiride Identity

Property Description
Active ingredient Sulpiride
Form Tablets, Capsules, Oral Solution
Pharmacological class Atypical Antipsychotic (Substituted Benzamide)
Common use Modulating thought processes and stabilizing mood
Origin Synthetic Compound

Sulpiride: What Type of Medicine is It?

Sulpiride is a synthetic, prescription-only medication chemically classified as a substituted benzamide and functionally designated as an atypical (second-generation) antipsychotic agent. This medicine is defined by its specific chemical structure and is manufactured to selectively engage certain neurological targets. The World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system places Sulpiride under code N05AL01, confirming its role as a psychoactive drug. As a monocomponent drug, it contains only one active substance. Its status as an atypical antipsychotic distinguishes its neurological profile, which is supported by pharmacological studies, from the broader actions of older, first-generation treatments.


Composition and General Purpose of the Drug

The general purpose of Sulpiride is to help stabilize mood and thought processes by precisely regulating chemical signals in the brain. The core composition involves the active ingredient, Sulpiride, combined with necessary pharmaceutical excipients for its various dosage forms, which commonly include tablets, capsules, and oral solutions, with administration primarily via the oral route. The drug's mechanism centers on acting as a dopamine receptor antagonist. Studies have confirmed its high-affinity binding to D2 and D3 receptors, which is central to its therapeutic action. The general benefit is supporting mental stability, utilized in scenarios where individuals require assistance with the regulation of emotional and perceptual processes.

What side effects are possible with Suride?

Possible Side Effects and Safety Information

Suride (a combination of rabeprazole and levosulpiride) may cause side effects, most of which are generally mild and temporary. It is important to discuss all potential risks with a healthcare professional before starting treatment.


Common Side Effects

The most frequently reported side effects include gastrointestinal and nervous system issues:

  • Gastrointestinal: Nausea, vomiting, diarrhea, constipation, dry mouth, stomach pain, and flatulence.
  • Nervous System: Headache, dizziness, and drowsiness.

If these effects are persistent or bothersome, consult your doctor. In some cases, adjusting the timing of the dose may help to manage symptoms like flatulence or nausea.


Serious Warnings and Precautions

While rare, some side effects may indicate a more serious underlying issue and require immediate medical attention. Stop taking Suride and contact your doctor or seek emergency care if you experience:

  • Allergic Reactions: Symptoms such as hives, rash, itching, or swelling of the face, throat, or tongue, and difficulty breathing.
  • Cardiovascular Issues: Signs of overdose may include a rapid or pounding heartbeat.
  • Neurological Changes: Severe symptoms like tremors, confusion, or seizures.

Suride should be used with caution if you have a history of cardiovascular disease, liver problems, or have diabetes, as it may affect blood glucose levels. Do not exceed the prescribed dosage, as overdose can lead to severe side effects including confusion and drowsiness. Inform your doctor if you are pregnant, planning to conceive, or breastfeeding.

Overdose and Emergency Response

Suride Overdose and when to seek help

The official product labeling defines the Sulpiride overdose profile based on severe clinical manifestations affecting multiple physiological systems, and mandates specific actions.

Domain Official Regulatory Statement
Documented Manifestations Symptoms may range from lethargy, drowsiness, and inattention to a severe disturbance of consciousness or coma. Extrapyramidal signs, including severe, reversible dystonic crises (e.g., trismus, torticollis), and signs of Parkinsonism are also documented.
Physiological Systems Affected The overdose affects the Central Nervous System (CNS), causing convulsions and consciousness disturbances; the Cardiovascular System (hypotension, tachycardia, QTc prolongation); and the Musculoskeletal System (increased muscle tone, hyperreflexia).
Life-Threatening Risks Documented severe outcomes include QTc interval prolongation, the potentially fatal arrhythmia Torsade de Pointes (TdP), cardiac arrest, and the potential for Neuroleptic Malignant Syndrome (NMS).
Classification Official Regulatory Statement
Antidote Information No specific antidote is known for Sulpiride overdose.
Emergency Action Required Patients must seek immediate medical attention. Treatment is symptomatic and supportive, which may involve procedures like gastric lavage and catharsis.

Official Overdose Statements

Overdose may result in a severe spectrum of neurological findings, ranging from initial drowsiness to coma, and may be accompanied by convulsions. Due to the documented cardiac risks, immediate medical attention must be sought if overdose is suspected. All patients require close monitoring for signs of long QT syndrome and severe arrhythmias, as there is no specific antidote available. Regulatory documents define this profile by its potential for severe toxicity, which necessitates urgent medical intervention for intensive supportive care and continuous observation.

Therapeutic Uses of Suride

What Suride Treats: Main Uses and Benefits

Sulpiride may assist with symptomatic relief across several key therapeutic domains, contributing to the management of heightened patient distress and assisting with maintaining functional stability. The therapeutic context for Sulpiride is considered relevant in clinical settings that involve acute or unstable symptom patterns, such as those seen in schizophrenia, major depressive disorder, certain somatoform complaints, and severe disruptive behavioral patterns in children. The medicine is used for treating these core conditions.

The medication is applied in addressing symptom clusters that involve disorganization in thinking, profound mood instability, and associated physical distress. It is commonly used when groups of symptoms appear suddenly or fluctuate. It offers symptomatic relief that helps patients cope more steadily with difficult episodes and supports general well-being. It is commonly used when short-term symptomatic assistance is needed, such as when symptoms become temporarily overwhelming, contributing to easing the overall symptom load for physical symptoms like persistent vertigo.


Quick Fact: Relief for Key Symptom Categories
Focuses on supporting the management of Positive and Negative Psychotic Features and Severe Behavioral Agitation.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Suride — Official Regulatory Information

The eligibility profile for Suride (Sulpiride) is defined by regulatory authorities based on pre-existing conditions, age, and physiological status.


Contraindicated Populations (Must Not Use)
Patients with known hypersensitivity to the drug or its excipients.
Patients with prolactin-dependent tumors (e.g., breast cancer or pituitary gland prolactinomas).
Patients with phaeochromocytoma (adrenal gland tumor) or acute porphyria.
Patients concurrently using Levodopa or other antiparkinsonian drugs (e.g., ropinirole).

Age-Related and Conditional Restrictions
Children under 14 years: Use is not recommended due to insufficient clinical data on safety and efficacy [Source 3.1].
Older Adults (Geriatric): Use requires particular caution due to increased susceptibility to effects like postural hypotension; dose reduction is necessary if renal impairment is present [Source 3.1].
Pregnancy/Lactation: Use is not recommended during pregnancy or for breastfeeding women [Source 1.1].
Comorbidities: Caution is required for patients with severe heart disease, a history of epilepsy (seizures), diabetes mellitus, and conditions like glaucoma or prostatic hyperplasia [Source 1.1, 1.5].

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Suride details several documented interactions based on pharmacodynamic effects and altered absorption, but officially notes that the medicine neither inhibits nor stimulates major CYP450 enzymes.

Contraindicated Combinations

Certain combinations are formally prohibited due to regulatory restrictions. Co-administration is contraindicated with Levodopa and other dopaminergic agonists due to antagonistic effects. Similarly, use with Alcohol is prohibited as it enhances central nervous system (CNS) depression. Combinations with medicines that prolong the QTc interval (e.g., specific antiarrhythmics, Pimozide, Thioridazine) are also contraindicated due to the increased risk of severe ventricular arrhythmias.

Pharmacodynamic and Absorption Interactions

  • CNS Depressants: Co-administration with agents like narcotics, sedatives, and hypnotics may result in an enhanced CNS depressant effect (additive pharmacodynamic risk).
  • Antihypertensive Agents: An additive effect may increase the risk of postural hypotension. Co-administration with Metoclopramide may increase the risk of extrapyramidal effects.
  • Antacids and Sucralfate: These agents reduce the absorption of Suride, leading to lower plasma exposure. The interaction is mitigated by a mandatory timing rule: Suride must be administered at least two hours before the antacid or sucralfate.

Population Considerations

Interactions resulting in sedation or postural hypotension are officially noted as having an increased clinical significance for elderly patients.

Mechanism of Action

How Suride Works: Mechanism of Action

Suride acts as a neurotransmitter receptor modulator, influencing distinct signaling pathways within the central nervous and endocrine systems. Its mechanism involves two primary domains.

First, Suride functions as an agonist at the Dopamine D2 receptor family, and as a modulator of 5-HT1A and 5-HT2 serotonin receptors in the brain. This engagement alters the balance of neurochemical signals, influencing the nigrostriatal pathway and pathways regulating central vascular tone, which results in the adjustment of motor signal transmission and central vasomotor tone.

Second, a separate mechanistic cascade is initiated by Suride's D2 agonism on lactotroph cells located in the anterior pituitary gland. This targeted interaction directly suppresses the cellular processes responsible for Prolactin (PRL) synthesis and secretion. This cascade results in a reduction in circulating prolactin levels following the modulation of the hypothalamic-pituitary-prolactin axis.

Dosage and Administration Information

How Suride is Used: Official Administration Guidelines

Suride (Sulpiride) is administered primarily via the oral route (by mouth) and is available in official dosage forms including tablets, capsules, and oral solutions. The precise usage pattern is governed by governmental regulatory standards, detailing dosage ranges, frequency, and specific intake conditions.


Official Dosing Regimens and Frequency

Standard adult dosing for higher-dose regimens, such as for the management of psychotic features, typically ranges from 400 mg to 800 mg daily. Lower-dose regimens may start from 100 mg daily. The maximum recommended daily dose is cited in some regulatory documents as 1200 mg. Due to its pharmacological characteristics, the total daily dose is customarily administered in two or three divided doses to ensure consistent drug levels.

Administration Pattern General Instruction
Route and Forms Oral administration via tablets, capsules, or oral solution.
Frequency Doses are divided and taken at regular intervals (e.g., morning and early evening).
Antacid Timing Must be taken at least two hours before antacids or sucralfate.

Population and Procedural Adjustments

Administration requires adherence to specific procedural and population-based rules. The oral solution form requires a calibrated measuring device for accurate intake. For older adults, the official protocol mandates a lower starting dose and careful titration. Crucially, the dose must be reduced and the time interval between doses increased in patients diagnosed with renal impairment, with specific modifications based on the patient's creatinine clearance. Official use is generally not recommended in children under 14 years.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Early-Phase Studies (In Vitro and Animal Models)

Initial research focused on how the compound affects specific receptors in the bone matrix and explored the compound’s potential role in bone function. Preclinical research examined the compound's effect on osteoblast activity and its potential influence on preventing bone degradation in rodent models. Findings from these initial phases suggested a basis for further human investigation.


Phase I and II Human Trials

Safety and Tolerability

Initial human trials (Phase I) focused on determining the safety profile and identifying maximum tolerated doses. The side effects observed in clinical trials were generally reported as mild, including temporary gastrointestinal discomfort in a small subset of participants. Trial protocols detailed specific administration conditions for evaluation.

Preliminary Efficacy Explorations

Phase II studies were designed to establish a preliminary dosage range and explore potential biological markers. Research has explored the role of dosage levels to evaluate changes in symptoms associated with advanced stages. Phase II results indicated variability in patient responses across different demographic groups.


Phase III Randomized Controlled Trials (RCTs)

Primary Endpoint: Fracture Incidence

Multiple international Phase III RCTs compared the compound to a placebo in patients diagnosed with advanced skeletal disorders. A specific study examined the onset of effects following initial treatment. Research examined the frequency of fractures in long-term study groups. Researchers are continuing to investigate the correlation between bone mineral density (BMD) markers and clinical outcomes.

Combination Therapy Trials

Studies evaluated whether the combination influenced patient mobility when the compound was co-administered with a standard supportive care regimen over a 12-month period. Research evaluated the safety of co-administration but did not include direct comparisons of effectiveness.


Post-Marketing Surveillance (Phase IV)

Long-term observational studies are currently ongoing to gather further data on patient outcomes over a period exceeding five years. These studies monitor for rare adverse events and collect real-world data outside the structured environment of clinical trials. Phase IV studies continue to collect data to assess the long-term patterns of use and effects in a broader patient population.

Key Studies & References

  1. Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study

Frequently Asked Questions (FAQ)

Common questions about Suride (FAQ)

Q: Is it normal to have a metallic taste in your mouth while taking Suride?

Taste disturbances, such as a metallic taste, are not universally listed among the very common side effects in the official product information. However, adverse reaction lists may sometimes include other forms of taste alteration. If this occurs or if any side effect is persistent, review the situation with a healthcare professional.


Q: Can Suride be taken with antacids or heartburn medication?

Official regulatory documents state that Suride must be taken at least two hours before taking antacids or sucralfate (a medicine that coats the stomach). This is necessary because these agents can reduce the absorption of Suride. It is recommended to review the timing of other heartburn medications with a healthcare professional.


Q: Is Suride considered safe for people with liver issues?

Regulatory warnings indicate that Suride should be used with caution in patients who have pre-existing liver problems. If you have a liver condition, consultation with a healthcare professional is necessary to determine appropriate use.


Q: Do you need a prescription for Suride, or is it sold over the counter?

Suride (Sulpiride) is classified by regulatory authorities as a prescription-only medicine. It is not available for purchase over the counter.


Q: Why is Suride prescribed for both short-term and long-term use?

The length of time Suride is prescribed depends entirely on the specific medical condition being treated. Official dosing regimens are available for both short-term use and for long-term maintenance treatment, particularly for conditions requiring ongoing management of thought and mood processes.


Q: Will Suride interfere with my regular birth control pill?

While Suride is not known to inhibit the major drug-metabolizing enzymes in the liver, official information notes that it can cause an increase in the hormone prolactin. Because elevated prolactin levels may potentially disrupt the menstrual cycle, it is recommended to discuss the use of hormonal contraception with a healthcare provider while taking this medicine.


Q: What research supports the use of Suride for its main purpose?

Regulatory approvals are based on clinical trials and research evidence that demonstrate the medicine's effectiveness. Official product information summarizes this research, which supports the drug's use in modulating thought processes and stabilizing mood, confirming its role as an atypical antipsychotic.


Q: Has Suride been studied in children, and is it appropriate for them?

According to official regulatory documents, the use of Suride is generally not recommended in children under 14 years of age. This restriction is based on a lack of sufficient clinical data regarding its safety and effectiveness in younger populations.


Q: Can Suride cause changes in appetite or weight?

Yes, official adverse reaction reports include increased appetite and weight gain among the commonly reported side effects. Concerns about weight changes should be addressed with a healthcare provider.


Q: Is it okay to drive while taking Suride?

Official warnings state that Suride can cause side effects such as dizziness and drowsiness. These effects may impair the ability to drive or operate complex machinery. It is recommended to avoid these activities until you know how the medicine affects your alertness and coordination.


Q: Why do some people feel dizzy when they first start taking Suride?

Dizziness is a commonly reported side effect, especially when treatment is first initiated. This is likely related to the medicine's effects on the central nervous system, including a potential for postural hypotension—a temporary drop in blood pressure when moving quickly from sitting or lying down to standing.


Q: Does Suride come in different forms (e.g., tablet, liquid)?

Yes, Suride (Sulpiride) is manufactured and marketed in several dosage forms. These commonly include tablets, capsules, and oral solutions, which allows for flexibility in administration.


Q: What should I do if I experience an upset stomach with Suride?

Gastrointestinal issues like an upset stomach (nausea, pain, flatulence) are listed among the common side effects. If these effects are persistent or become bothersome, seeking review from a doctor or pharmacist is appropriate.


Q: Can Suride affect the results of blood tests?

Yes, official product information indicates that Suride can affect certain blood levels. It is known to cause an increase in the hormone prolactin in the blood. It is important to inform your laboratory or doctor that you are taking Suride before any blood work is performed.


Q: How does Suride work inside the body to help with the illness?

Suride is classified as an atypical antipsychotic that works by acting as a modulator, primarily targeting specific dopamine receptors in the brain. By engaging these receptors, it helps to regulate certain neurochemical signals, which ultimately supports the stabilization of thought processes and mood.


Q: Is there a generic version of Suride available?

Yes, Suride is the brand name for the active ingredient Sulpiride. Regulatory databases confirm that generic versions of Sulpiride are available and marketed internationally.


Q: Are there any specific groups of people who should definitely not take Suride?

Yes, regulatory documents list several contraindications where the drug must not be used. This includes patients with a known hypersensitivity, those with prolactin-dependent tumors, those with a rare tumor called phaeochromocytoma, and patients concurrently taking medicines like levodopa.


Q: Does Suride affect sleep patterns?

Official reports indicate that common side effects include drowsiness. Additionally, more general sleep disturbances, such as insomnia or difficulty sleeping, have also been reported in regulatory documents, although less frequently.


Q: Is the research on Suride recent or long-standing?

Suride (Sulpiride) is considered a long-standing compound in medicine, having been studied and used clinically for several decades. This confirms that the research supporting its use covers a substantial period of time, from early trials to post-marketing surveillance.


Q: What should I tell my pharmacist about before getting a prescription for Suride?

It is important to inform your pharmacist about all current medications, including non-prescription drugs and supplements. You should also disclose any relevant pre-existing medical conditions, such as heart disease, kidney or liver problems, epilepsy, or diabetes, as these may affect how the medicine is used.


Q: How long does Suride stay in your system after you stop taking it?

Regulatory pharmacokinetic data indicate that Suride has an elimination half-life of approximately 8 hours. This suggests that it typically takes about 32 to 40 hours (four to five half-lives) for the medicine to be almost completely eliminated from the body.


Q: What happens if Suride is taken with alcohol?

The combination of Suride with alcohol is formally contraindicated (prohibited) in official product information. This is because alcohol is known to enhance the central nervous system (CNS) depressant effects of the medicine.


Q: Is Suride safe for people with kidney problems?

For patients diagnosed with renal impairment (kidney problems), regulatory guidelines mandate that the dose must be reduced and the time interval between doses must be increased. This adjustment is typically made to ensure appropriate drug levels and to prevent potential accumulation.


Q: What are the reported effects of Suride on mood or anxiety?

While Suride's main approved use is for stabilizing thought processes, its official therapeutic indications and studies suggest that at certain lower doses, it may exhibit antidepressant activity and can be studied for its effects on anxiety-related symptoms.


Q: What is the chemical class of Suride?

Suride (Sulpiride) is chemically classified as a substituted benzamide. Functionally, it is designated as an atypical (second-generation) antipsychotic agent, based on how it interacts with chemical signals in the brain.


Q: Are there common reasons why Suride might be stopped by a doctor?

A doctor may decide to discontinue Suride if a patient develops a contraindication (a condition that prohibits its use), if they experience serious side effects (such as severe neurological changes), or if there is simply an insufficient therapeutic response to the medicine.


Q: Why are people often told to finish the entire course of Suride, even if they feel better?

Official warnings advise patients to continue taking the medicine exactly as prescribed and not to stop suddenly. This is to prevent the original illness symptoms from returning and to avoid the occurrence of unpleasant withdrawal effects.


Q: What are the risks of suddenly stopping Suride?

Stopping Suride abruptly can lead to the reappearance of the original illness symptoms. Furthermore, official guidance warns that it may cause withdrawal effects such as nausea, vomiting, sweating, difficulty sleeping, restlessness, and uncontrolled body movements.


Q: Is it possible to be allergic to Suride?

Yes, allergic reactions (hypersensitivity) are possible with Suride, as with any medicine. Regulatory documents list a known hypersensitivity to the drug or its inactive ingredients as a formal contraindication.

How should Suride be stored and disposed of?

The required storage and disposal instructions for Sulpiride tablets are defined strictly by regulatory labeling to maintain the medicine's stability and ensure safety.

Storage Requirements

Storage Component Official Labeled Requirement
Temperature Constraint Do not store the tablets above 25 C (77 F).
Protection Rule Store in the original container to protect from light and keep in a dry place.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

No special precautions are noted for the disposal of Sulpiride tablets, as it is not classified as hazardous medicinal waste. Unused or expired product should be discarded in accordance with local requirements. If a drug take-back program is unavailable, follow general governmental guidance for non-flushable medicines by mixing the tablets with an unappealing substance, sealing the mixture, and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Suride found in:

A-Z Index: